Lv5
1080 积分 2023-12-24 加入
Discovery of the first dual PD-L1/JAK inhibitor with enhanced in vivo antitumor immunity
1天前
求助中
Therapeutic inhibition of USP7 promotes antitumor immune responses
1个月前
已完结
Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies
1个月前
已完结
New KV7.2/3 Channel Activators Exhibit Superior Toxicity and Metabolic Profiles to Flupirtine and Demonstrate Promising In Vivo Analgesic Effects
3个月前
已完结
Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials
4个月前
已完结
Signal pathways of melanoma and targeted therapy
4个月前
已完结
Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents
4个月前
已完结
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation
4个月前
已完结
Discovery and Crystallography Study of Novel Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment
5个月前
已完结
Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy
6个月前
已完结
皖公网安备34019202002308
